Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Non-local robust detection of DTI white matter differences with small databases.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
The relation between peptide hormones and sex hormone in patients with multiple sclerosis.
Biologically plausible and evidence-based risk intervals in immunization safety research.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Information regarding Active Biotech's candidate drug laquinimod
Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin.
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
Fast Whole-Brain Three-dimensional Macromolecular Proton Fraction Mapping in Multiple Sclerosis.
Life-threatening asthma attack during prolonged fingolimod treatment: case report.
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Value of NMO-IgG determination at the time of presentation as CIS.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?
Central nervous system myeloid cells as drug targets: current status and translational challenges.
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Fingolimod protects cultured cortical neurons against excitotoxic death.
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Purkinje cell pathology and loss in multiple sclerosis cerebellum.
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS

Pages